Truist cuts Nike stock price target on sportswear pressure By Investing.com

Truist cut its Nike price target to $57 from $69 and expects meaningfully more pressure through end-2026; NKE trades at $52.82, down 27.88% over six months and near its 52-week low of $50.95. Nike reported fiscal Q3 2026 revenue of $11.3B (vs $11.23B est.) and EPS $0.35 (vs $0.30 est.), but multiple analysts (Jefferies, BTIG, Barclays, Stifel) lowered targets citing channel mix, prolonged cleanup and Greater China reset issues. Overall the earnings beat is overshadowed by cautious analyst outlooks and macro/sportswear headwinds, supporting continued downside risk near-term.

Analysis

Nike’s current reset is behaving like a multi-quarter inventory-normalization rather than a short blip: wholesale reorder cadence is likely to remain suppressed for 6–12 months, forcing continued promotional intensity and margin headwinds even if demand stabilizes. That extends pressure to upstream suppliers (cutting order books for leather, textile and midstream component makers) and to logistics volumes out of Southeast Asia, which should weigh on freight-dependent cost pass-through and supplier FCF profiles.

The most important competitive dynamic is segmentation: Nike’s performance franchise can still generate higher-margin growth pockets that mask headline weakness in sportswear, creating a two-speed recovery internally and giving branded challengers an opening to steal low-price-point share in key markets. A slower Greater China rebound or protracted markdown cycle benefits nimble regional brands and discounters while increasing the probability of promotional parity across tier-1 retailers, compressing industry gross margins.

Key catalysts to watch are (1) a clear, multi-quarter wholesale inventory drawdown reported by large retail partners (3–6 months), (2) visible acceleration in newness sell-through during the next seasonal launch (60–90 days), and (3) any behaviorally-driven capital allocation shift (share buybacks vs. working capital) at the next board decision. Tail risks that would reverse a recovery include a macro shock that depresses discretionary spend for 4+ quarters or a repeat of container-rate spikes that materially raise landed costs into peak season; both scenarios keep volatility elevated and create cheap option-hedge opportunities.

Key Decisions for Investors

• Tactical hedged-long NKE (9–15 months): buy Jan-2027 LEAP calls 25–35% OTM and sell a nearer-term (3–6 month) call 10–15% OTM to fund ~30–40% of premium. R/R: asymmetric upside if newness/stewardship shows traction (>2x upside), capped carry from sold call; downside limited to net premium (~100% downside of premium paid).
• Near-term defensive short (0–3 months): buy a 3-month NKE put spread 10–20% OTM to express continued markdown / wholesale risk around next retail inventory prints. R/R: small known cost for >2–3x payoff if markdowns accelerate; low gamma vs. outright short.
• Relative-value rotation (3–9 months): pair trade long SMCI (buy 3–6 month call spread or outright long) vs. short NKE (equal notional put spread). Rationale: capital rotation from lagging consumer names into high-beta tech should amplify relative returns; target 20–30% relative outperformance with capped option-defined downside.
• Selective growth reallocation (6–12 months): accumulate APP on pullbacks via 6–12 month calls or buy-write to capture reacceleration in ad monetization as institutional flows reallocate from weak consumer positions. R/R: moderate asymmetry (1.5–2x) with high liquidity to exit into any broad risk-off.